The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Open accessAbstract
Background & aims Intestinal dysbiosis and bacterial translocation are common in patients with advanced liver disease, and there is strong evidence that the translocation of bacteria and their products across the epithelial barrier drives experimental liver disease progression. The aims of our study were to investigate dynamics of bacterial translocation and changes in the enteric microbiome in early stages of liver disease.Methods Cholestatic liver injury was induced by ligation of the common bile duct (BDL) and toxic liver injury by injection of carbon tetrachloride (CCl(4)) in mice.Results Increased intestinal permeability and bacterial translocation occurred one day following liver injury in both disease models. This was accompanied by decreased intestinal expression of the tight junction protein occludin. Although BDL resulted in a rapid onset of intestinal bacterial overgrowth, bacterial overgrowth was observed in mice injected with CCl(4) only in advanced stages of liver fibrosis. To further assess the qualitative changes in the intestinal microbiome, massively parallel pyrosequencing of 16S rRNA genes revealed minor microbial changes following BDL, while CCl(4) administration resulted in a relative abundance of Firmicutes and Actinobacteria compared with oil-injected mice. Four different liver disease models (cholestasis, toxic, alcohol, obesity) show few similarities in their intestinal microbiome.Conclusions Acute liver injury is associated with an early onset of increased intestinal permeability and bacterial translocation that precede changes in the microbiome. The enteric microbiome differs with respect to the etiology of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in blood LPS levels reflect gut leakiness and are mirrored by a number of other alterations such as increased intestinal permeability to high molecular weight polyethylene glycol in patients with ALD26 and to FITC-dextran in mouse models of alcoholic and biliary liver disease27,28.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [28]
In the citing paper
“Decreased bile secretion in rodents by either ligation of the common bile duct or induction of cirrhosis contributes to bacterial translocation, which is not only caused by intestinal bacterial overgrowth but also by increased gut permeability20,28,134.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [28]
In the citing paper
“Moreover, there are very limited available studies focused on characterising the microbiome composition during experimental cholestasis and these studies have shown conflicting results25,26.”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [26]
In the citing paper
“In addition, microbiome analysis was performed at later timepoints (10 days) after BDL, while our analyses comprised earlier timepoints after surgery; 3 and 7 days after BDL.”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [26]
In the citing paper
“While Fouts et al.26 described that BDL did not alter the microbiome in mice, Alaish et al.25 described changes in Bl6/C57 mice at late stages after BDL (14 days) that the authors discussed to be associated with advanced fibrogenesis (cirrhosis).”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [26]
In the citing paper
“Also, the sequencing methodology used in that study was different that the one we have applied. Fouts and colleagues used pyrosequencing26 while we used Illumina sequencing in our work, which provides a higher number of sequences per sample and greater depth of sequences corresponding to the hypervariable zone V3-V4, as opposed to the hypervariable V1–V3 region targeted in the Fouts et al. work26.”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simpson, E. (1949) · Nature · doi:10.1038/163688a0 · Cited by 14,809
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationMetagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Self-citationIntestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Estimating the Population Size for Capture-Recapture Data with Unequal Catchability
Chao, A. (1987) · Biometrics · doi:10.2307/2531532 · Cited by 2,459
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citation
Cited by
Sorted by citations
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Self-citationFibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cai, J., Sun, L., & Gonzalez, F. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.004 · Cited by 892
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 715
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Bernardi, M., Moreau, R., Angeli, P., Schnabl, B., & Arroyo, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.004 · Cited by 645
Self-citationIntestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 574
Bull–Otterson, L., Feng, W., Kirpich, I., Wang, Y., Qin, X., Liu, Y., Gobejishvili, L., Joshi‐Barve, S., Ayvaz, T., Petrosino, J. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053028 · Cited by 553
Gut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490
Balmer, M. L., Slack, E., de Gottardi, A., Lawson, M. A. E., Hapfelmeier, S., Miele, L., Grieco, A., Van Vlierberghe, H., Fahrner, R., Patuto, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008618 · Cited by 470
Intestinal fungi contribute to development of alcoholic liver disease
Yang, A., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90562 · Cited by 470
Self-citationKummen, M., Holm, K., Anmarkrud, J. A., Nygård, S., Vesterhus, M., Høivik, M. L., Trøseid, M., Marschall, H.-U., Schrumpf, E., Moum, B., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310500 · Cited by 426
Alcohol's Effect on Host Defense
Szabó, G. (2015) · Alcohol research · doi:10.35946/arcr.v37.2.01 · Cited by 419
Wang, L., Fouts, D. E., Stärkel, P., Hartmann, P., Chen, P., Llorente, C., DePew, J., Moncera, K. J., Ho, S. B., Brenner, D. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.003 · Cited by 387
Self-citationGut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 375
Hendrikx, T., Duan, Y., Wang, Y., Oh, J., Alexander, L. M., Huang, W. J. M., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 376
Self-citationChen, P., Torralba, M., Tan, J., Embree, M., Zengler, K., Stärkel, P., van Pijkeren, J.-P., DePew, J., Loomba, R., Ho, S. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.014 · Cited by 322
Self-citationZhou, X., Li, J., Guo, J., Geng, B., Ji, W., Zhao, Q., Li, J., Liu, X., Liu, J., Guo, Z.-Z., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0441-4 · Cited by 314
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 302
Self-citationEmerging roles of bile acids in mucosal immunity and inflammation
Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 305
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology · doi:10.1002/hep.26695 · Cited by 279
Dietary fat, bile acid metabolism and colorectal cancer
Ocvirk, S., & O’Keefe, S. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.003 · Cited by 266
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257
Self-citationMethods to determine intestinal permeability and bacterial translocation during liver disease
Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257
Self-citationSorribas, M., Jakob, M. O., Yılmaz, B., Li, H., Stutz, D., Noser, Y., Gottardi, A. D., Moghadamrad, S., Hassan, M., Albillos, A., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.017 · Cited by 258
Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice
Gong, S., Lan, T., Zeng, L., Luo, H., Yang, X., Li, N., Chen, X., Liu, Z., Li, R., Win, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.024 · Cited by 254
Self-citationMicrobiome as a therapeutic target in alcohol-related liver disease
Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 254
Self-citationDevelopmental origins of NAFLD: a womb with a clue
Wesolowski, S. R., Kasmi, K. C. E., Jonscher, K. R., & Friedman, J. E. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.160 · Cited by 239
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., & Wu, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.634780 · Cited by 237
Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
Ahluwalia, V., Betrapally, N. S., Hylemon, P. B., White, M. B., Gillevet, P. M., Unser, A. B., Fagan, A., Daita, K., Heuman, D. M., Zhou, H., et al. (2016) · Scientific Reports · doi:10.1038/srep26800 · Cited by 213
Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity
Jensen, I. J., Sjaastad, F. V., Griffith, T. S., & Badovinac, V. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701618 · Cited by 206
Hendrikx, T., & Schnabl, B. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12892 · Cited by 204
Self-citationCommensal microbiota is hepatoprotective and prevents liver fibrosis in mice
Mazagova, M., Wang, L., Anfora, A. T., Wissmueller, M., Lesley, S. A., Miyamoto, Y., Eckmann, L., Dhungana, S., Pathmasiri, W., Sumner, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-259515 · Cited by 199
Self-citationCigarette smoking and liver diseases
Marti-Aguado, D., Clemente-Sanchez, A., & Bataller, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.016 · Cited by 190
The pathophysiology of intrahepatic cholestasis of pregnancy
Dixon, P. H., & Williamson, C. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.12.008 · Cited by 198
Nagpal, R., Newman, T. M., Wang, S., Jain, S., Lovato, J. F., & Yadav, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3462092 · Cited by 178
Psychotropics and the Microbiome: a Chamber of Secrets…
Cussotto, S., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5185-8 · Cited by 176
Mátyás, C., Haskó, G., Liaudet, L., Trojnár, E., & Pacher, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0433-5 · Cited by 152
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives
Malaguarnera, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16639 · Cited by 149
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Perugorria, M. J., Esparza-Baquer, A., Oakley, F., Labiano, I., Korosec, A., Jais, A., Mann, J., Tiniakos, D., Santos-Laso, A., Arbelaiz, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314107 · Cited by 144
Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
Lin, R., Zhou, L., Zhang, J., & Wang, B. (2015) · PubMed Central · Cited by 142
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Ponziani, F. R., Zocco, M. A., Cerrito, L., Gasbarrini, A., & Pompili, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1481747 · Cited by 139
Chen, M., Liu, J., Yang, W., & Ling, W. (2017) · Autophagy · doi:10.1080/15548627.2017.1356550 · Cited by 134
Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 143
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
Pijls, K. E., Jonkers, D. M. A. E., Elamin, E. E., Masclee, A., & Koek, G. H. (2013) · Liver International · doi:10.1111/liv.12271 · Cited by 124
Janssen, A. W. F., Houben, T., Katiraei, S., Dijk, W., Boutens, L., van der Bolt, N., Wang, Z., Brown, J. M., Hazen, S. L., Mandard, S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075713 · Cited by 121
Juanola, O., Ferrusquía‐Acosta, J., García-Villalba, R., Zapater, P., Magaz, M., Marín, A., Olivas, P., Baiges, A., Bellot, P., Turón, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901327r · Cited by 125
Hartmann, P., Haimerl, M., Mazagova, M., Brenner, D. A., & Schnabl, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.099 · Cited by 119
Self-citationBile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D. A., & Wan, Y. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 119
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice
Kang, D. J., Betrapally, N. S., Ghosh, S., Sartor, R. B., Hylemon, P. B., Gillevet, P. M., Sanyal, A. J., Heuman, D. M., Carl, D. E., Zhou, H., et al. (2016) · Hepatology · doi:10.1002/hep.28696 · Cited by 116
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Hartmann, P., Chen, W., & Schnabl, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00402 · Cited by 110
Self-citationLiu, R., Kang, J. D., Sartor, R. B., Sikaroodi, M., Fagan, A., Gavis, E. A., Zhou, H., Hylemon, P. B., Herzog, J., Li, X., et al. (2019) · Hepatology · doi:10.1002/hep.30827 · Cited by 107
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
PBHMDA: Path-Based Human Microbe-Disease Association Prediction
Huang, Z.-A., Chen, X., Zhu, Z., Liu, H., Yan, G., You, Z., & Wen, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00233 · Cited by 99
The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 102
Role of Gut Microbiota in Liver Disease
Brenner, D. A., Paik, Y., & Schnabl, B. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000391 · Cited by 94
Self-citationLight exposure influences the diurnal oscillation of gut microbiota in mice
Wu, G., Tang, W., He, Y., Hu, J., Gong, S., He, Z., Wei, G., Lv, L., Jiang, Y., Zhou, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.095 · Cited by 93
A Current Understanding of Bile Acids in Chronic Liver Disease
Farooqui, N., Elhence, A., & Shalimar, S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.08.017 · Cited by 94
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
Anto, L., & Blesso, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108991 · Cited by 90
Raevens, S., Boret, M., & Fallon, M. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100527 · Cited by 85
Toll-like receptors in the pathogenesis of pulmonary fibrosis
Karampitsakos, Τ., Woolard, T., Bouros, D. E., & Τzouvelekis, Α. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.045 · Cited by 86
Linking intestinal homeostasis and liver disease
Schnabl, B. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835ff948 · Cited by 83
Self-citationTsiaoussis, G. I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2058 · Cited by 83
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
Rockey, D. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.01.005 · Cited by 82
Detection technologies and metabolic profiling of bile acids: a comprehensive review
Liu, Y., Rong, Z., Xiang, D., Zhang, C., & Liu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0774-9 · Cited by 78
Twardowska, A., Makaro, A., Binienda, A., Fichna, J., & Sałaga, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063204 · Cited by 84
The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
Schrumpf, E., Kummen, M., Valestrand, L., Greiner, T. U., Holm, K., Arulampalam, V., Reims, H. M., Baines, J. F., Bäckhed, F., Karlsen, T. H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.020 · Cited by 80
Lü, M., Tang, Y., Li, M., Yang, P., Liu, Z., Yuan, J., & Zheng, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138078 · Cited by 78
Hackstein, C.-P., Assmus, L. M., Welz, M., Klein, S., Schwandt, T., Schultze, J. L., Förster, I., Gondorf, F., Beyer, M., Kroy, D. C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311224 · Cited by 83
Harris, J. K., Kasmi, K. C. E., Anderson, A. L., Devereaux, M. W., Fillon, S., Robertson, C. E., Wagner, B. D., Stevens, M. J., Pace, N. R., & Sokol, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110396 · Cited by 77
Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C. J., Mitchell, M. C., McCullough, A. J., Dasarathy, S., Kroll‐Desrosiers, A., et al. (2019) · Hepatology · doi:10.1002/hep.30617 · Cited by 75
Targeting gut flora to prevent progression of hepatocellular carcinoma
Darnaud, M., Faivre, J., & Moniaux, N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.019 · Cited by 76
Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
Pandey, S. P., Bender, M. J., McPherson, A. C., Phelps, C. M., Sanchez, L. M., Rana, M., Hedden, L., Sangani, K. A., Chen, L., Shapira, J. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.05.006 · Cited by 72
Chen, J., Xuan, Y.-H., Luo, M.-X., Ni, X.-G., Ling, L.-Q., Hu, S.-J., Chen, J.-Q., Xu, J., Jiang, L., Si, W.-Z., et al. (2019) · Toxicology · doi:10.1016/j.tox.2019.152338 · Cited by 71
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 74
Liu, R., Li, X., Huang, Z., Zhao, D., Sukka-Ganesh, B., Lai, G., Pandak, W. M., Hylemon, P. B., Bajaj, J. S., Sanyal, A. J., et al. (2017) · Hepatology · doi:10.1002/hep.29540 · Cited by 70
Alcohol-associated bowel disease: new insights into pathogenesis
Maccioni, L., Fu, Y., Horsmans, Y., Leclercq, I., Stärkel, P., Kunos, G., & Gao, B. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100013 · Cited by 69
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver
Lutz, P. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.304 · Cited by 67
An interdisciplinary review of the thanatomicrobiome in human decomposition
Javan, G. T., Finley, S. J., Tuomisto, S., Hall, A., Benbow, M. E., & Mills, D. (2018) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-018-0061-0 · Cited by 68
Kumar, M., Leon‐Coria, A., Cornick, S., Petri, B., Mayengbam, S., Jijon, H. B., Moreau, F., Shearer, J., & Chadee, K. (2020) · Nature Communications · doi:10.1038/s41467-019-14182-2 · Cited by 68
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Self-citationMechanisms of sepsis-induced acute liver injury: a comprehensive review
Guo, Y., Guo, W., Chen, H., Sun, J., & Yin, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1504223 · Cited by 73
Liver Injury and the Activation of the Hepatic Myofibroblasts
Jiang, J. X., & Torok, N. J. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0019-6 · Cited by 70
Said, M. M., Azab, S. S., Saeed, N. M., & El-Demerdash, E. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8662 · Cited by 65
Hansen, N. W., & Sams, A. (2018) · Nutrients · doi:10.3390/nu10111590 · Cited by 65
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Gadaleta, R. M., Cariello, M., Crudele, L., & Moschetta, A. (2022) · Nutrients · doi:10.3390/nu14153212 · Cited by 67
Ge, X., Leung, T., Arriazu, E., Lu, Y., Urtasun, R., Christensen, B., Fiel, M. I., Mochida, S., Sφrensen, E. S., & Nieto, N. (2013) · Hepatology · doi:10.1002/hep.26931 · Cited by 65
Alcohol Use As a Risk Factor in Infections and Healing: A Clinician's Perspective
Trevejo-Nuñez, G. (2015) · Alcohol research · doi:10.35946/arcr.v37.2.03 · Cited by 65
Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
Cabrera-Rubio, R., Patterson, A. M., Cotter, P. D., & Beraza, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-48784-z · Cited by 61
Current progress of research on intestinal bacterial translocation
Wang, Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104652 · Cited by 63
Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models
Raevens, S., & Fallon, M. B. (2018) · Hepatology · doi:10.1002/hep.30079 · Cited by 60
Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
Wan, S., Liu, C., Huang, C., Luo, F., & Zhu, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01321 · Cited by 60
Gut microbiome-brain-cirrhosis axis
Smith, M. L., Wade, J. B., Wolstenholme, J. T., & Bajaj, J. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000344 · Cited by 65
Metadata
- Authors
- Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B.
- Affiliations
- J. Craig Venter Institute (US)
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 56
- Issue
- 6
- Pages
- 1283-1292
- ISSN
- 0168-8278 (ISSN-L)
- PMC
- PMC3357486
- OpenAlex
- W2153223490
- Cited by
- 311
- References
- 52
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 13 · 2023: 24 · 2022: 21 · 2021: 26 · 2020: 31 · 2019: 27 · 2018: 34 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 21 · 2013: 18 · 2012: 11
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of California, San Diego
- National Institute on Alcohol Abuse and Alcoholism (R01AA020703)
- National Institute of General Medical Sciences (R01GM041804)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK080506, DK 080506, R01DK072237, K08DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- bacterial translocation, gut microbiota, gut dysbiosis, intestinal permeability, occludin, tight junctions, cholestatic liver injury, common bile duct ligation, carbon tetrachloride, liver fibrosis, Firmicutes, actinobacteria, alcoholic liver disease
- MeSH terms
- Animals, Carbon Tetrachloride, Cholestasis, Disease Models, Animal, Intestines, Liver Diseases, Male, Mice, Inbred BALB C, Permeability, Bacterial Translocation, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
